Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome
- 1 July 2018
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 31 (7), 1141-1154
- https://doi.org/10.1038/s41379-018-0014-x
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid Leukemia: An Algorithmic Approach Using High-Resolution Melting Curve AnalysisThe Journal of Molecular Diagnostics, 2011
- inv(16)(p13q22) in Chronic Myelogenous Leukemia in Blast PhaseAmerican Journal of Clinical Pathology, 2005
- Role of Tyrosine Kinase Inhibitors in Cancer TherapyThe Journal of pharmacology and experimental therapeutics, 2005
- Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformationBone Marrow Transplantation, 2004
- Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndromeLeukemia, 2003
- A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemiasBlood, 2002
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaThe New England Journal of Medicine, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeThe New England Journal of Medicine, 2001
- Acute Leukemias Expressing p210-and p190-Type bcr/ abl mRNAs: Report of Two Cases and Review of the LiteratureActa Haematologica, 1996
- Late-appearing Philadelphia chromosome in acute lymphoblastic leukemiaCancer Genetics and Cytogenetics, 1990